Sutro Biopharma Earnings Perspective: Return On Capital Employed - Benzinga

Retrieved on: 2021-11-11 17:01:22

Tags for this article:

Click the tags to see associated articles and topics

Sutro Biopharma Earnings Perspective: Return On Capital Employed - Benzinga. View article details on HISWAI: https://www.benzinga.com/news/earnings/21/11/24043655/sutro-biopharma-earnings-perspective-return-on-capital-employed

Excerpt

Benzinga Pro data, Sutro Biopharma (NASDAQ:STRO) reported Q3 sales of $8.52 million. Earnings fell to a loss of $34.67 million, resulting in a ...

Article found on: www.benzinga.com

View Original Article